USP37 and breast cancer: Moreover, in vivo xenograft mouse model of breast cancer showed that tumors resulting from USP37 silenced cells are more sensitive to cisplatin, and have impaired HH target and stemness genes expression, together with lower proliferation ability compared to control group [131].